Active: Response to platinum-based chemotherapy in non-small-cell lung cancer Clear all

GWAS 2023-02-07

Establishing a Prediction Model for the Efficacy of Platinum-Based Chemotherapy in NSCLC Based on a Two Cohorts GWAS Study.

Xiao Q, Mao C et al.

J Clin Med

Platinum drugs combined with other agents have been the first-line treatment for non-small cell lung...

Response to platinum-based chemotherapy in non-small-cell lung cancer

217

Participants

N/A

Studies

Details PubMed

GWAS 2021-10-16

Genome-wide analysis identify novel germline genetic variations in <i>ADCY1</i> influencing platinum-based chemotherapy response in non-small cell lung cancer.

Mao C, Chen J et al.

Acta Pharm Sin B

To explore the pharmacogenomic markers that affect the platinum-based chemotherapy response in non-s...

Response to platinum-based chemotherapy in non-small-cell lung cancer

Replicated

296

Participants

N/A

Studies

Details PubMed

GWAS 2018-03-01

Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2.

Galván-Femenía I, Guindo M et al.

Cancer Treat Res Commun

Objective: The aim of the study was to investigate the relationship between germline variations as a...

Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)

Replicated

537

Participants

N/A

Studies

Details PubMed

GWAS 2012-08-07

Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.

Hu L, Wu C et al.

Clin Cancer Res

Purpose: Genetic variation may influence chemotherapy response and overall survival in cancer patien...

Response to platinum-based chemotherapy in non-small-cell lung cancer

Replicated

1277

Participants

N/A

Studies

Details PubMed

GWAS 2011-04-11

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.

Wu X, Ye Y et al.

J Natl Cancer Inst

Interindividual variation in genetic background may influence the response to chemotherapy and overa...

Response to platinum-based chemotherapy in non-small-cell lung cancer

Replicated

1062

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Establishing a Prediction Model for the Efficacy of Platinum-Based Chemotherapy in NSCLC Based on a Two Cohorts GWAS Study.

Xiao Q, Mao C et al.

J Clin Med

Response to platinum-based chemotherapy in non-small-cell lung cancer

2023-02-07

Genome-wide analysis identify novel germline genetic variations in <i>ADCY1</i> influencing platinum-based chemotherapy response in non-small cell lung cancer.

Mao C, Chen J et al.

Acta Pharm Sin B

Response to platinum-based chemotherapy in non-small-cell lung cancer

2021-10-16

Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2.

Galván-Femenía I, Guindo M et al.

Cancer Treat Res Commun

Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)

2018-03-01

Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.

Hu L, Wu C et al.

Clin Cancer Res

Response to platinum-based chemotherapy in non-small-cell lung cancer

2012-08-07

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.

Wu X, Ye Y et al.

J Natl Cancer Inst

Response to platinum-based chemotherapy in non-small-cell lung cancer

2011-04-11